Skip to search formSkip to main contentSkip to account menu

Tanderil

Known as: Novartis Ophthalmics Brand of Oxyphenbutazone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
ALG-1001 (Luminate, Allegro Ophthalmics) has a number of different mechanisms of action that benefit patients chronically treated… 
1973
1973
The penetration of [14C]-labelled oxyphenbutazone (OPB = active substance of Tanderil® eye ointment) from a 10-percent eye… 
1972
1972
Oxyphenbutazone (Tanderil - Geigy), a pyrazole compound, is a metabolite of phenylbutazone, and has long been available for… 
1971
1971
Testing the ocular side effects of new drugs, it is not sufficient to investigate cataractogenic effects in normal lenses. Some… 
1966
1966
THE clinical impression of one of us (D.W.S.) that oxyphenbutazone (Tanderil) had a markedly beneficial effect on episcleritis… 
Review
1965
Review
1965
Already the change from the antipyretic antipyrine, synthesized by L. Knorr (1) in 1883, to aminopyrine, which has not only an… 
1960
1960
Summary35 patients were treated with Tanderil for about 3 weeks (21.1. days on an average). Later 7 patients with rheumatoid…